Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP347652.RAkp-2_zfun5FBrTsV5aWVCExTYFqN4cf-GfX5-O6B_AM130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347652.RAkp-2_zfun5FBrTsV5aWVCExTYFqN4cf-GfX5-O6B_AM130_provenance.
• NP928492.RAapWmGCnY2ozHR3FXCpjzbzR59lOUTzjn0YjVoWoiUdQ130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928492.RAapWmGCnY2ozHR3FXCpjzbzR59lOUTzjn0YjVoWoiUdQ130_provenance.
• NP729610.RAaoWP7diNreWsg4aqLHQ9ZbKNyKhSgKUG7lgBsZWD_vo130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP729610.RAaoWP7diNreWsg4aqLHQ9ZbKNyKhSgKUG7lgBsZWD_vo130_provenance.
• NP586008.RAc0rqV0Kan7zkNWdQqilIohOKw76Qh83xHdN7zWMV8IE130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586008.RAc0rqV0Kan7zkNWdQqilIohOKw76Qh83xHdN7zWMV8IE130_provenance.
• NP657071.RAdkwBh4vtt9KcY1u6KM2W1UeuOzHkNXWidcTVRGEEiVk130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657071.RAdkwBh4vtt9KcY1u6KM2W1UeuOzHkNXWidcTVRGEEiVk130_provenance.
• assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591909.RANOGRElUT6YhK2LWRMZD_bVB2FjjNOmqRWSwUWfHqBe8130_provenance.
• assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586279.RAA_JDFZTMFQhqF6q0foCgaS66am4cJf4xjTJj2qx4OeU130_provenance.
• NP586276.RAfn-KeJfWPrPEkAEpj5TBfH4U-PzE07-RkBn9rWYcTdw130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586276.RAfn-KeJfWPrPEkAEpj5TBfH4U-PzE07-RkBn9rWYcTdw130_provenance.
• NP586278.RAXufB1B-m00T6kpGvHSZVEHI_cwHPm0unfsTU_YqzgSo130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586278.RAXufB1B-m00T6kpGvHSZVEHI_cwHPm0unfsTU_YqzgSo130_provenance.
• NP670881.RAE1aCBUrfbop81RNeHOgyFKoTg4glPPkU48VGztPOuIU130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670881.RAE1aCBUrfbop81RNeHOgyFKoTg4glPPkU48VGztPOuIU130_provenance.
• NP573115.RAjWjiNFSiWAodJniFZQGM4QJpF10Qmy1WuSDMfzJQ__Y130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573115.RAjWjiNFSiWAodJniFZQGM4QJpF10Qmy1WuSDMfzJQ__Y130_provenance.
• NP573117.RA07jKoRovHRNJdXDqZ6XmUsae_9FHvXInqtBs5L0AQl8130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573117.RA07jKoRovHRNJdXDqZ6XmUsae_9FHvXInqtBs5L0AQl8130_provenance.
• NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657066.RAN-UquKRJtCRiBKP8bKNfpbL0HbL8T8Wg2ALGbySb7Tg130_provenance.
• NP586277.RA2gN_4PWLiHXXt-DdXcBJxzpJ5AYxsmuKYkkWCZtAqi4130_assertion description "[The products of COX-2 and LOX activities have been implicated in cytokine-mediated damage of beta-cells, so selective inhibitors of these enzymes would be expected to have a dual protective role in diabetes: they would minimize beta-cell dysfunction while maintaining insulin secretion through enhancing endogenous arachidonic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586277.RA2gN_4PWLiHXXt-DdXcBJxzpJ5AYxsmuKYkkWCZtAqi4130_provenance.